tiprankstipranks
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
1513
Livzon Pharmaceutical Group
RESEARCH TOOLSreports
Want to see HK:1513 full AI Analyst Report?

Livzon Pharmaceutical Group (1513) Revenue

1 Followers
StatisticsMarket CapRevenue

Livzon Pharmaceutical Group Revenue

Livzon Pharmaceutical Group had a revenue of 2.12B in the quarter ending Jun 30, 2026, with -26.17%. This bring the company's revenue in the last twelve months to 10.70B, Increased -8.33%. In the fiscal year ending Dec 31, 2025, Livzon Pharmaceutical Group had annual revenue of 12.02B with 1.76% growth.
Revenue (ttm)
10.70B
Revenue Growth
-5.90%
P/S Ratio
2.04
Revenue/Employee
HK$1,353,948
Employees
8,878
Market Cap
HK$24.53B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
12.02B208.01M+1.76%
Dec 31, 2024
11.81B-617.70M-4.97%
Dec 31, 2023
12.43B-199.54M-1.58%
Dec 31, 2022
12.63B565.72M+4.69%
Dec 31, 2021
12.06B1.54B+14.67%
Dec 31, 2020
10.52B1.14B+12.10%
Dec 31, 2019
9.38B524.04M+5.91%
Dec 31, 2018
8.86B329.69M+3.86%
Dec 31, 2017
8.53B――